Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. (2018). SKIN The Journal of Cutaneous Medicine, 2(S1), S20. https://doi.org/10.25251/skin.2.supp.20